June 9 (Reuters) - U.S. Food and Drug Administration:

* U.S. FDA - on June 8, 2017, U.S. Food and Drug Administration approved the first generic version of Truvada for the treatment of HIV-1 Source text: (bit.ly/2sbknAI) (Bengaluru Newsroom: +91 806 749 1136)